CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX)

24 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q4 2024.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.84M shares of 15M outstanding shares and own 12.31% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (507K shares), VANGUARD GROUP INC (374K shares), DIMENSIONAL FUND ADVISORS LP (273K shares), ACADIAN ASSET MANAGEMENT LLC (188K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (184K shares), Bank of New York Mellon Corp (75.3K shares), GEODE CAPITAL MANAGEMENT, LLC (74.3K shares), BlackRock, Inc. (42.6K shares), TWO SIGMA INVESTMENTS, LP (37.6K shares), and STATE STREET CORP (33.7K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.